jain rk et al. (2006) lessons from phase iii clinical trials on anti-vegf therapy for cancer
Post on 30-Dec-2015
20 Views
Preview:
DESCRIPTION
Table 3 Completed Phase III trials for multi-targeted agents with VEGF receptor 2 kinase as one of their targets. Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer Nat Clin Pract Oncol 3: 24 –40 doi:10.1038/ncponc0403. - PowerPoint PPT Presentation
TRANSCRIPT
Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancerNat Clin Pract Oncol 3: 24–40 doi:10.1038/ncponc0403
Table 3 Completed Phase III trials for multi-targeted agents with VEGF receptor 2 kinase as one of their targets
top related